Stay updated on Immunotherapy with Nivolumab in HIV+ Patients Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy with Nivolumab in HIV+ Patients Clinical Trial page.

Latest updates to the Immunotherapy with Nivolumab in HIV+ Patients Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now shows a new revision tag: Revision: v3.6.3, replacing Revision: v3.6.2. This indicates a version update for the page content/assets.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.2 on the page, indicating a system update. This change does not alter the trial details, eligibility criteria, or any content shown to users.SummaryDifference0.0%

- Check33 days agoChange DetectedThe page now indicates that recruitment has ended for this study and adds user-focused sections such as How to Read a Study Record, Common Questions, and How to Join a Study. The Intervention label is updated to Intervention/Treatment and a new revision note (Revision: v3.6.0) appears, replacing the prior v3.5.5 note.SummaryDifference0.4%

- Check40 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a new version of the page.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page now shows Revision: v3.5.4, indicating a new version was published as part of routine updates or QC. This does not alter the study content, eligibility, or results.SummaryDifference0.0%

- Check83 days agoChange DetectedThe page footer was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a minor change to the site’s current version display.SummaryDifference0.0%

Stay in the know with updates to Immunotherapy with Nivolumab in HIV+ Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy with Nivolumab in HIV+ Patients Clinical Trial page.